Status
Global HQ
Rockville, United States
Countries of investment
Investment stages
Industries
About
The National Foundation for Cancer Research (NFCR) is a premier nonprofit organization committed to accelerating the development of innovative immunotherapy solutions for the treatment, management, and potential cure of various forms of cancer. Established in 1973, NFCR has been at the forefront of funding transformative cancer research, fostering collaborations among world-renowned scientists, and facilitating the translation of laboratory discoveries into clinical applications. By supporting cutting-edge studies and promoting education and awareness, NFCR aims to improve patient outcomes and ultimately eradicate cancer in all its forms.
The National Foundation for Cancer Research (NFCR) is a premier nonprofit organization committed to accelerating the development of innovative immunotherapy solutions for the treatment, management, and potential cure of various forms of cancer. Established in 1973, NFCR has been at the forefront of funding transformative cancer research, fostering collaborations among world-renowned scientists, and facilitating the translation of laboratory discoveries into clinical applications. By supporting cutting-edge studies and promoting education and awareness, NFCR aims to improve patient outcomes and ultimately eradicate cancer in all its forms.
Investment Thesis
Manager's Experience
With a robust background in private equity, the fund manager has successfully executed over 20 investments across the technology and healthcare sectors in North America and Europe. Recognized for a data-driven strategy, they excel in identifying high-growth opportunities at the growth stage, leading to notable exits that have consistently outperformed market benchmarks. Their operator-first approach allows for hands-on involvement in portfolio companies, enhancing operational efficiencies and driving value creation. This strategic focus positions them as a key player in navigating complex investment landscapes.